A human study by Vrieze et al. demonstrated that transfer of intestinal microbiota from lean donors could increase insulin sensitivity in individuals with metabolic syndrome, along with increased levels of butyrate-producing intestinal microbiota [37]. The gene discussed is INS; the disease is metabolic syndrome.